U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06928363) titled 'A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.' on March 31.
Brief Summary: This trial is a first-in-human, multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of KY-0301 as monotherapy in patients with advanced solid tumors. This trial will be conducted at approximately multi-sites nationwide, and approximately110~212 participants with unresectable locally advanced or metastatic solid tumors will be invited to participate. The study consists of three parts: Phase I dose escalation & dose expansion phases of KY-0301 as monother...